Kampanjeplan uniQure
Avansert tidsplan
Enkel graf
Om selskapet uniQure
uniQure NV - компания, специализирующаяся на генной терапии. Он разрабатывает лечение и платформу для пациентов, страдающих генетическими и другими серьезными заболеваниями. Его продукты и услуги ориентированы на гемофилию, болезнь Хантингтона и сердечно-сосудистые заболевания. В сотрудничестве с Bristol Myers-Squibb компания сосредоточена на разработке линейки генных методов лечения сердечно-сосудистых заболеваний.IPO date | 2007-06-20 |
---|---|
ISIN | NL0010696654 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.uniqure.com |
Цена ао | 13.85 |
Prisendring per dag: | -1.01% (15.83) |
---|---|
Prisendring per uke: | +11.53% (14.05) |
Prisendring per måned: | -9.68% (17.35) |
Prisendring over 3 måneder: | +139.79% (6.535) |
Prisendring over seks måneder: | +105.37% (7.63) |
Prisendring per år: | +168.78% (5.83) |
Prisendring over 3 år: | -0.6971% (15.78) |
Prisendring over 5 år: | -56.93% (36.38) |
Prisendring over 10 år: | -53.1% (33.41) |
Prisendring siden begynnelsen av året: | -9.68% (17.35) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
Nantahala Capital Management, LLC | 5916054 | 12.37 |
Vestal Point Capital, LP | 3925000 | 8.2 |
State Street Corporation | 3478872 | 7.27 |
Blackrock Inc. | 1836696 | 3.84 |
Morgan Stanley | 1759818 | 3.68 |
683 Capital Management LLC | 1693000 | 3.54 |
Orbimed Advisors LLC. | 1347900 | 2.82 |
Pictet Asset Management Holding SA | 1324246 | 2.77 |
International Biotechnology Trust PLC | 1241500 | 2.6 |
Schroder Investment Management Group | 1241500 | 2.6 |
ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
---|---|---|---|
Virtus LifeSci Biotech Clinical Trials ETF | 0.80858 | 63.04 | 0.33 |
Global X Genomics & Biotechnology ETF | 0.412 | 2.58 | 0.15585 |
ProShares UltraShort Nasdaq Biotechnology | 0.35 | -40.36 | 1.76 |
Avantis U.S Small Cap Equity ETF | 0.02943 | 27.77 | 1.68271 |
Invesco Nasdaq Biotechnology ETF | 0.02658 | 28.58 | 0.8565 |
Principal Healthcare Innovators ETF | 0.02271 | 618.5 | 0.8416 |
Future Tech ETF | 0.02271 | 426.34 | 0.8416 |
Invesco FTSE RAFI US 1500 Small-Mid ETF | 0.02226 | 17.58 | 1.75869 |
ProShares Ultra Nasdaq Biotechnology | 0.01858 | 51.7 | 0.85651 |
Schwab U.S. Small-Cap ETF | 0.00652 | 17.47 | 1.51433 |
Avantis U.S. Equity ETF | 0.00076 | 23.04 | 1.59151 |
Schwab U.S. Broad Market ETF | 0.00043 | 24.86 | 1.43354 |
0.14 | 105.09 | 1.14 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Mr. Matthew Craig Kapusta | CEO & Executive Director | 1.16M | 1972 (53 år) |
Mr. Christian Klemt | CFO, Principal Financial Officer & GM of Amsterdam Site | 566.36k | 1973 (52 år) |
Prof. Hugo Katus | Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany | N/A | |
Ms. Maria E. Cantor | Chief Corporate Affairs Officer | 491.12k | 1968 (57 år) |
Dr. Tamara Tugal Ph.D., MBA | Business Development Director | N/A | |
Dr. Jeannette Potts J.D., Ph.D. | Chief Legal & Compliance Officer and Corporate Secretary | N/A | 1962 (63 år) |
Mr. Richard Porter Ph.D. | Chief Business & Scientific Officer | N/A | 1968 (57 år) |
Dr. Amin Abujoub Ph.D. | Chief Technical Operations | N/A | |
Dr. Walid Abi-Saab M.D. | Chief Medical Officer | 1965 (60 år) | |
Eileen Sawyer | Vice President of Global Medical Affairs |
Adresse: Netherlands, Amsterdam BP, Paasheuvelweg 25a - åpne i Google maps, åpne Yandex-kart
Nettsted: http://www.uniqure.com
Nettsted: http://www.uniqure.com